Legal Representation
Attorney
Tomoko Nakajima
USPTO Deadlines
Next Deadline
2149 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-05-27)
Due Date
May 27, 2031
Grace Period Ends
November 27, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 eventsDate | Code | Type | Description |
---|---|---|---|
May 27, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
May 27, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
May 9, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Apr 22, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Apr 22, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Apr 8, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Apr 8, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
Apr 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Mar 11, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Mar 4, 2025 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Mar 4, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Mar 4, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Nov 7, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
Nov 7, 2024 | GNFR | O | FINAL REFUSAL E-MAILED |
Nov 7, 2024 | CNFR | R | FINAL REFUSAL WRITTEN |
Sep 14, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Sep 14, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Sep 14, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Apr 30, 2024 | RFNT | P | REFUSAL PROCESSED BY IB |
Apr 11, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Apr 11, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU |
Mar 23, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Mar 22, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
Mar 15, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
Dec 15, 2023 | CORR | I | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED |
Nov 26, 2023 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB |
Oct 27, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
Oct 23, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Oct 19, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 009
Telecommunications devices, apparatus and instruments, namely, transmitters and cables; electronic machines, apparatus and their parts, namely, computer hardware; downloadable computer programs for treating sleep disorders and insomnia; smart phones; tablet computers; downloadable music files that can be received and stored using the Internet; downloadable image files that can be received and stored using the Internet featuring medical information for the treatment of sleep disorders and insomnia; downloadable electronic publications featuring medical information for the treatment of sleep disorders and insomnia
Class 010
Medical equipment for analyzing and measuring sleep state excluding walking aids and crutches, namely, medical devices for testing sleep disorders, medical devices for treating sleep disorders
Class 042
Design, creation, and maintenance of computer programs for use in treating sleep disorders and insomnia; providing temporary use of online non-downloadable computer software programs for use in treating sleep disorders and insomnia
Class 044
Provision of medical information; medical examination services; nutritional and dietary consultancy; medical equipment rental
Additional Information
Design Mark
The mark consists of the blue wording "MED CBT-I" in the center of a blue and gray circle. Two smaller blue circles with blue lines appear to the left of the wording, separating the blue and gray portions of the circle. All appear on a white background.
Color Claim
The color(s) blue, gray and white is/are claimed as a feature of the mark.
Pseudo Mark
MEDICAL CBT I
Classification
International Classes
009
010
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MED CBT-I"